High income (World Bank) vs Norway: Domestic general government health expenditure (GGHE-D) per capita in
High income (World Bank)
2,613
in 2023
Norway
7,144
in 2023
High income (World Bank) rank
1st
Norway rank
3rd
Domestic general government health expenditure (GGHE-D) per capita in over time
- High income (World Bank)
- Norway
How they compare
Norway currently reports 7,144 against 2,613 in High income (World Bank), a difference of 4,531.
That makes Norway's figure about 2.7 times High income (World Bank)'s.
Across all 24 years both countries report, Norway has been ahead every year.
High income (World Bank) ranks 1st and Norway ranks 3rd of 11 groups.
Norway has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | High income (World Bank) | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1,290 | 4,431 | 3,140 | Norway |
| 2010s | 2,010 | 7,088 | 5,078 | Norway |
| 2020s | 2,547 | 7,297 | 4,750 | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher domestic general government health expenditure (gghe-d) per capita in, High income (World Bank) or Norway?
- Norway, at 7,144 against 2,613 in High income (World Bank) as of 2023.
- What is the difference in domestic general government health expenditure (gghe-d) per capita in between High income (World Bank) and Norway?
- 4,531, with Norway ahead.
- How many years of comparable data are there for High income (World Bank) and Norway?
- 24 years are reported by both, from 2000 to 2023.
- How do High income (World Bank) and Norway rank globally for domestic general government health expenditure (gghe-d) per capita in?
- High income (World Bank) ranks 1st and Norway ranks 3rd of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Domestic general government health expenditure (GGHE-D) per capita in US$. Statizoid refreshes it automatically from the source and publishes the full history for both places.